Thus, at least in T-ALL, there may be an attenuation of the classical inhibitory effect of AMPK signaling on mTORC1 through the phosphorylation of tuberous sclerosis 2 or hamartin and raptor. This evidence concerns the gene TSC1 and acute lymphoblastic leukemia.